Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study - Test2 - elhamkhani - TriplyDB

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

http://www.wikidata.org/entity/Q24653790

about

Meta-regression analyses, meta-analyses, and trial sequential analyses of the effects of supplementation with beta-carotene, vitamin A, and vitamin E singly or in different combinations on all-cause mortality: do we have evidence for lack of harm?The effectiveness of the McKenzie method in addition to first-line care for acute low back pain: a randomized controlled trial Causal assessment of dietary acid load and bone disease: a systematic review & meta-analysis applying Hill's epidemiologic criteria for causality Systematic review of influenza resistance to the neuraminidase inhibitors Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)Sulfonylurea versus metformin monotherapy in patients with type 2 diabetes: a Cochrane systematic review and meta-analysis of randomized clinical trials and trial sequential analysis Oxygen therapy for acute myocardial infarction Lateral positioning for critically ill adult patients Dipeptidyl-peptidase (DPP)-4 inhibitors or glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus Interventions for the prevention of type 2 diabetes mellitus in women with previous gestational diabetes Fructose substitution of glucose or sucrose in food for normoglycaemic persons or people with or at risk of diabetes Probiotic fermented milk or isolated probiotic bacteria for primary prevention of cardiovascular disease in adults Self management interventions for type 2 diabetes in adult people with severe mental illness Sodium-glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus Thrombolysis for acute upper extremity deep vein thrombosis Continued lamivudine for adults with lamivudine-resistant chronic hepatitis B virus infection Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus Interferon for people with lamivudine-resistant chronic hepatitis B virus infection Direct-acting antivirals for chronic hepatitis C Exercise-based cardiac rehabilitation for adults after heart valve surgery Diet, physical activity, and behavioural interventions for the treatment of overweight or obesity in preschool children up to the age of 6 years Comparison of central adjudication of outcomes and onsite outcome assessment on treatment effect estimates N-acetylcysteine for non-paracetamol (acetaminophen)-related acute liver failure Sodium-glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for development of type 2 diabetes mellitus Lorcaserin for overweight or obese adults Radioiodine therapy versus antithyroid medications for Graves' disease Rehabilitation following carpal tunnel release Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma Hydroxychloroquine for systemic lupus erythematosus in adults Ayurvedic herbal preparations for hypercholesterolaemia Acupuncture for adults with type 2 diabetes mellitus Cerebral near-infrared spectroscopy monitoring for prevention of brain injury in very preterm infants Early versus delayed post-operative bathing or showering to prevent wound complications Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis Interventions to improve water quality for preventing diarrhoea Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma Prolonged storage of packed red blood cells for blood transfusion Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis Aromatase inhibitors for short stature in male children and adolescents Non-invasive positive pressure ventilation for acute asthma in children

P2860

Q21090716-C5106731-2AA6-4B12-9D73-20D9CFCDA932 Q21245263-8711F874-7E45-40EA-9E9F-9C93E6C33CE6 Q21245925-02641739-7818-4C38-BED9-36D80E67E871 Q21261835-DEC2FF3C-F137-426D-AE78-AA0DE8E736B7 Q22061981-49894664-9C73-47C0-A8A4-E37D7C505DB1 Q22241119-6106DEAF-00CE-4746-81C8-76A44C85130B Q22252969-88BE5D1B-DCE4-460C-A710-1056478DD87C Q24185770-02E24F25-0889-4606-B397-5BAF3B41B780 Q24185805-0FE31F85-01A0-4DD2-B678-D12CC1E93E67 Q24185836-3C44D49D-8AF4-478F-9540-B0036B27B7D0 Q24185843-458C6BF2-6E4D-4AB9-8BF7-3DD42BF27052 Q24185844-F198B310-CD0E-4523-AFF2-FE91297D0359 Q24185857-D2A01CA8-A313-4358-B5E1-899D8151AE76 Q24185874-6649DAA5-D64E-4088-B9C9-143EB2C1969D Q24185948-3FB2B5D1-0C6B-4C3F-968F-6297A34A8DEB Q24185958-470D0AF8-9001-40CB-B3A0-7EE694B0F3F8 Q24185970-FEB875B8-B4B5-41DE-A68F-AA725A650ED9 Q24185973-A7E6414E-D3B8-4CA5-B4E5-1050187C8AB6 Q24185977-B45E3881-B44A-403D-B3C9-F942E0D5BBC5 Q24186018-FB30D4FF-1CA1-4AD7-98B0-413E6BCB3BB9 Q24186038-6C397B52-94CD-4B35-8E9B-3C5CC62EA7B2 Q24186056-EF77F0BF-067C-4B61-9DC9-DA747D0A1D18 Q24186061-CF766F38-D142-4B47-B6B5-50573AA90F48 Q24186087-C4C4EFBA-36C2-4274-9ED7-5B6BE3A1551E Q24186092-53637F0F-CB60-4DB6-99FD-F2903AD872EF Q24186122-3FBDE53A-45C2-4ACA-83CF-2B8F59EDF1BB Q24186128-8B74CAE9-D436-46FA-85E6-54795C17F47F Q24186130-30B48CAD-D92F-483A-BF8E-16D9D4A324B6 Q24186197-38381D12-B852-4261-B14B-B195350A88CE Q24186216-41A1322E-6F91-42B8-A394-CAAEFE201DD6 Q24186271-6562E280-48E6-4E75-AAC3-27AD84C9140F Q24186335-5FD8C811-788B-42A6-8DFF-CD1016E1F288 Q24186337-0063C009-7A64-482A-8E6A-FEFAFAF5F19E Q24186409-CF52A889-6144-4750-A5FF-E961B54C7EFE Q24186452-C1C39E7B-400D-413C-BB38-B0DB252C71C5 Q24186496-2608463E-2580-43B7-8ABD-BC6547B59078 Q24186513-0D3F4F17-B114-49B2-B597-8EECA1D599DC Q24186554-68D77779-F2C9-4E75-94E2-D1E2C081A622 Q24186574-0392E566-D3B8-4728-A89B-D87CABB1A9FD Q24186648-73F141E8-93E5-48AD-8B4C-EB3128DB52C2

P2860

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

http://www.wikidata.org/entity/Q24653790

description

2008 nî lūn-bûn

@nan

2008 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մարտին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Empirical evidence of bias in ...... es: meta-epidemiological study

@ast

Empirical evidence of bias in ...... es: meta-epidemiological study

@en

Empirical evidence of bias in ...... es: meta-epidemiological study

@nl

type

label

Empirical evidence of bias in ...... es: meta-epidemiological study

@ast

Empirical evidence of bias in ...... es: meta-epidemiological study

@en

Empirical evidence of bias in ...... es: meta-epidemiological study

@nl

prefLabel

Empirical evidence of bias in ...... es: meta-epidemiological study

@ast

Empirical evidence of bias in ...... es: meta-epidemiological study

@en

Empirical evidence of bias in ...... es: meta-epidemiological study

@nl

P1433

Q24653790-F608D339-AD66-4F9B-BFC3-4F789CF27EE4

P1476

Q24653790-FF362E7D-ED01-496C-93F7-FF3DA0A27AB6

P2093

Q24653790-1CAEBC26-58E0-4449-8427-020389F11063

Q24653790-2EFB40DB-7F0E-4DF0-AC35-DF5ABABE84FD

Q24653790-57647FE8-96BE-4B51-88CD-C69A385153EE

Q24653790-DFBFF26B-68EF-4D05-9B02-B268571882E9

P2860

Q24653790-0D895FCE-47DB-4C79-83C5-573D9A492172

Q24653790-1DB92CAB-98FC-4514-A2C6-FABD458A6FA7

Q24653790-1F9E4744-67F5-473F-A1FC-027818A07EFA

Q24653790-23ACD025-CDAF-4500-B0A6-3A35286D13FB

Q24653790-2632AB9A-92E1-402E-A729-D606D6651AB0

Q24653790-303C11B4-BE6A-42B7-A5A5-481EB0070A15

Q24653790-39AE3920-488E-4FA4-93F8-4229324E4691

Q24653790-3E3B7BC6-68FC-4D93-9E21-D37A128A3B41

Q24653790-435B0A96-2498-4AF8-A913-A8133C826753

Q24653790-538E7357-5163-4B71-AB36-CF1210406915

P304

Q24653790-6F708195-635B-4FA3-8F0A-5401B5A240E9

P31

Q24653790-00C94FE0-46FE-4ED5-B7EC-FD5460DFCC7E

P3181

Q24653790-3692482A-C7C0-468B-924D-4F28257BC311

P356

Q24653790-92F889DB-247B-42F0-9D32-3927719E7234

P407

Q24653790-9E560B80-79FE-4FBB-9B90-CECE27BDAEC8

P433

Q24653790-66125C52-8DEE-49DE-930E-56E28F5E83FF

P478

Q24653790-6CE48953-E858-461B-ABF2-18047D12FF76

P50

Q24653790-3437C83E-52D6-44DA-84E6-056DF8AB5F31

Q24653790-3F4E6323-AA1A-4BD0-99B3-DA9ABEF83C9B

Q24653790-7EF687C2-7F99-48B8-AEBD-CA2888BFEE9D

Q24653790-882CFA74-2687-42A8-BE99-5B2598FAC58E

Q24653790-A7A7EF1C-1944-47D2-8371-736052B41A12

Q24653790-FB22D716-B032-4366-80A4-27A81AF57B85

P577

Q24653790-98A499B4-59BE-46AC-B64A-E22C33A2892E

P698

Q24653790-24899071-8C67-4A6F-95DC-299D866CAACE

P921

Q24653790-2FD76578-8820-4FBE-9F49-21A5A72B158F

Q24653790-8C52CE41-DD0D-4DFB-BB94-DBF21F34278F

P932

Q24653790-9404ADA4-E047-48AE-ABC5-5B290A67A2A3

P3181

P356

BMJ.39465.451748.AD

P1433

P1476

Empirical evidence of bias in ...... es: meta-epidemiological study

@en

P2093

Anthony J G Wood

http://www.w3.org/2001/XMLSchema#string

Jonathan A C Sterne

http://www.w3.org/2001/XMLSchema#string

Kenneth F Schulz

http://www.w3.org/2001/XMLSchema#string

Lesley Wood

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research

Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles

The revised CONSORT statement for reporting randomized trials: explanation and elaboration

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials.

Allocation concealment and blinding: when ignorance is bliss.

P304

601-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

152815

http://www.w3.org/2001/XMLSchema#string

P356

10.1136/BMJ.39465.451748.AD

http://www.w3.org/2001/XMLSchema#string

P407

P433

7644

http://www.w3.org/2001/XMLSchema#string

P478

336

http://www.w3.org/2001/XMLSchema#string

P50

Christian Gluud

Lise Lotte Gluud

Richard M Martin

Douglas G. Altman

P577

2008-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18316340

http://www.w3.org/2001/XMLSchema#string

P921

P932

2267990

http://www.w3.org/2001/XMLSchema#string